drugset / Trial / NCT04938713
Comparison of Ketamine and Esketamine in Patients Suffering From Fibromyalgia Syndrome.
Unknown
50 enrolled
Centre Hospitalier Universitaire de Charleroi
Centre Hospitalier Universitaire de Liege · collab
RandomizedCrossoverTriple-blindTreatment
Summary
Ketamine and Esketamine intravenous perfusions can modulate chronic pain. The purpose of this study is to determine if Ketamine or Esketamine are favorable for outpatients suffering from fibromyalgia.
Timeline
- Start
- 2021-07-01
- Primary completion
- 2022-05-01
- Completion
- 2022-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esketamine | Other / unclassified | 0.15 mg/kg | Intravenous |
| Subject | Ketamine | Small molecule | 0.3 mg/kg | Intravenous |